Evidence map›Paper›PMID 35456512›Full record

ReviewGenes2022

Pathogenesis of Type 1 Diabetes: Established Facts and New Insights.

Ana Zajec, Katarina Trebušak Podkrajšek, Tine Tesovnik, Robert Šket, Barbara Čugalj Kern, Barbara Jenko Bizjan, Darja Šmigoc Schweiger, Tadej Battelino, Jernej Kovač

Open access · goldAbstract readReview
In one paragraph

Review in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
16.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. ProtectiveiScience · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The Role of Vitamin D in Autoimmune Diseases.International journal of molecular sciences · 2026
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ana ZajecDivision of Paediatrics, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Katarina Trebušak PodkrajšekDivision of Paediatrics, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.ORCID 0000-0002-0154-3547
Tine TesovnikDivision of Paediatrics, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Robert ŠketDivision of Paediatrics, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Barbara Čugalj KernDivision of Paediatrics, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Barbara Jenko BizjanDivision of Paediatrics, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Darja Šmigoc SchweigerDivision of Paediatrics, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Tadej BattelinoDivision of Paediatrics, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.ORCID 0000-0002-0273-4732
Jernej KovačDivision of Paediatrics, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.ORCID 0000-0003-3080-4838
University of Ljubljana · SILjubljana University Medical Centre · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 1 diabetes (T1D) is an autoimmune disease characterized by the T-cell-mediated destruction of insulin-producing β-cells in pancreatic islets. It generally occurs in genetically susceptible individuals, and genetics plays a major role in the development of islet autoimmunity. Furthermore, these processes are heterogeneous among individuals; hence, different endotypes have been proposed. In this review, we highlight the interplay between genetic predisposition and other non-genetic factors, such as viral infections, diet, and gut biome, which all potentially contribute to the aetiology of T1D. We also discuss a possible active role for β-cells in initiating the pathological processes. Another component in T1D predisposition is epigenetic influences, which represent a link between genetic susceptibility and environmental factors and may account for some of the disease heterogeneity. Accordingly, a shift towards personalized therapies may improve the treatment results and, therefore, result in better outcomes for individuals in the long-run. There is also a clear need for a better understanding of the preclinical phases of T1D and finding new predictive biomarkers for earlier diagnosis and therapy, with the final goal of reverting or even preventing the development of the disease.

Indexed as

Diabetes Mellitus, Type 1Islets of LangerhansAutoimmunityEpigenomicsGenetic Predisposition to DiseaseHumansepigeneticsgeneticstype 1 diabetesviral infectionsβ-cell

Identifiers

PMID35456512
PMCPMC9032728
OpenAlexW4224104120

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.